Cas 438003-19-1,2-methyl-5-(1-pentanesulfonylcarbamoyl)-3-(4-(2-phenylethenyl)benzyl)indole

438003-19-1

Post Buying Request

Basic information

Product Name: 2-methyl-5-(1-pentanesulfonylcarbamoyl)-3-(4-(2-phenylethenyl)benzyl)indole
Synonyms: 2-methyl-5-(1-pentanesulfonylcarbamoyl)-3-(4-(2-phenylethenyl)benzyl)indole
CAS NO:438003-19-1
Molecular Formula:
Molecular Weight: 500.662
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-methyl-5-(1-pentanesulfonylcarbamoyl)-3-(4-(2-phenylethenyl)benzyl)indole(CAS DataBase Reference)
NIST Chemistry Reference: 2-methyl-5-(1-pentanesulfonylcarbamoyl)-3-(4-(2-phenylethenyl)benzyl)indole(438003-19-1)
EPA Substance Registry System: 2-methyl-5-(1-pentanesulfonylcarbamoyl)-3-(4-(2-phenylethenyl)benzyl)indole(438003-19-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 438003-19-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

438003-19-1 Suppliers

Recommended suppliers

438003-19-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 438003-19-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,8,0,0 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 438003-19:
(8*4)+(7*3)+(6*8)+(5*0)+(4*0)+(3*3)+(2*1)+(1*9)=121
121 % 10 = 1
So 438003-19-1 is a valid CAS Registry Number.

438003-19-1Upstream product

438003-19-1Downstream Products

438003-19-1Relevant academic research and scientific papers

Method for inhibiting neoplastic cells with indole derivatives

-

, (2008/06/13)

A method for inhibiting neoplastic cells and related conditions by exposing them to substituted indole derivatives.

REMEDIES FOR POLYCYSTIC OVARY SYNDROME

-

, (2008/06/13)

The present invention relates to a therapeutic agent for polycystic ovary syndrome, which comprises a compound of the following formula (1) or (2), or a pharmaceutically acceptable salt thereof as an active ingredient: wherein each symbol is as defined in the specification.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 438003-19-1